TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Nine Saturation Program Planning Winners Names NCI May Reissue RFP Later This Year May 23, 1975
TCL Archive AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation. April 14, 2006